null

SMILES: OC(=O)C[C@H](N(CC1CC1)Cc1ccc(OCCN2C(=O)CCC2=O)c(Cl)c1)c1ccc(Cl)c(F)c1

InChI Key: InChIKey=QFOOZQUUYROMBF-QFIPXVFZSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 249587   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
C-X-C motif chemokine 10 (Homo sapiens (Human))	BDBM249587 (US9447038, 15) Show SMILES OC(=O)C[C@H](N(CC1CC1)Cc1ccc(OCCN2C(=O)CCC2=O)c(Cl)c1)c1ccc(Cl)c(F)c1 |r| Show InChI InChI=1S/C26H27Cl2FN2O5/c27-19-5-4-18(12-21(19)29)22(13-26(34)35)30(14-16-1-2-16)15-17-3-6-23(20(28)11-17)36-10-9-31-24(32)7-8-25(31)33/h3-6,11-12,16,22H,1-2,7-10,13-15H2,(H,34,35)/t22-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	40	n/a	n/a	n/a	n/a	n/a	25
Sanofi US Patent					Assay Description The composition of the binding assay buffer is determined in a course of detailed optimization procedure. This resulted in a binding assay buffer con...				US Patent US9447038 (2016) BindingDB Entry DOI: 10.7270/Q29G5KQK
					More data for this Ligand-Target Pair
1,3-beta-glucan synthase component GSC2 (Saccharomyces cerevisiae)	BDBM249587 (US9447038, 15) Show SMILES OC(=O)C[C@H](N(CC1CC1)Cc1ccc(OCCN2C(=O)CCC2=O)c(Cl)c1)c1ccc(Cl)c(F)c1 |r| Show InChI InChI=1S/C26H27Cl2FN2O5/c27-19-5-4-18(12-21(19)29)22(13-26(34)35)30(14-16-1-2-16)15-17-3-6-23(20(28)11-17)36-10-9-31-24(32)7-8-25(31)33/h3-6,11-12,16,22H,1-2,7-10,13-15H2,(H,34,35)/t22-/m0/s1	KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
Sanofi Co. Ltd Curated by ChEMBL					Assay Description Inhibition of human ERG				Bioorg Med Chem Lett 26: 5429-5437 (2016) Article DOI: 10.1016/j.bmcl.2016.10.038 BindingDB Entry DOI: 10.7270/Q2514164
					More data for this Ligand-Target Pair
C-X-C chemokine receptor type 3 (Homo sapiens (Human))	BDBM249587 (US9447038, 15) Show SMILES OC(=O)C[C@H](N(CC1CC1)Cc1ccc(OCCN2C(=O)CCC2=O)c(Cl)c1)c1ccc(Cl)c(F)c1 |r| Show InChI InChI=1S/C26H27Cl2FN2O5/c27-19-5-4-18(12-21(19)29)22(13-26(34)35)30(14-16-1-2-16)15-17-3-6-23(20(28)11-17)36-10-9-31-24(32)7-8-25(31)33/h3-6,11-12,16,22H,1-2,7-10,13-15H2,(H,34,35)/t22-/m0/s1	UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	40	n/a	n/a	n/a	n/a	n/a	n/a
Sanofi Co. Ltd Curated by ChEMBL					Assay Description Displacement of [125I]-CXCL10 from human recombinant CXCR3 transfected in Flp-In-CHO cell membranes after 60 mins by gamma counting method				Bioorg Med Chem Lett 26: 5429-5437 (2016) Article DOI: 10.1016/j.bmcl.2016.10.038 BindingDB Entry DOI: 10.7270/Q2514164
					More data for this Ligand-Target Pair